DILH
REGN icon

Dai-ichi Life Holdings’s Regeneron Pharmaceuticals REGN Stock Holding History

Dai-ichi Life Holdings’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-10,434
Closed -$4.2M – 367
2016
Q3 		$4.2M Buy
10,434
+23
+0.2% +$9.23K 0.13% 180
2016
Q2 		$3.64M Sell
10,411
-234
-2% -$90.1K 0.11% 209
2016
Q1 		$3.84M Sell
10,645
-2,334
-18% -$962K 0.12% 196
2015
Q4 		$7.05M Sell
12,979
-294
-2% -$159K 0.22% 104
2015
Q3 		$6.17M Buy
13,273
+585
+5% +$314K 0.19% 118
2015
Q2 		$6.47M Sell
12,688
-3,379
-21% -$1.65M 0.19% 118
2015
Q1 		$7.25M Buy
16,067
+3,219
+25% +$1.36M 0.2% 110
2014
Q4 		$5.27M Buy
12,848
+6,602
+106% +$2.6M 0.15% 148
2014
Q3 		$2.25M Sell
6,246
-72
-1% -$24.1K 0.07% 297
2014
Q2 		$1.78M Buy
6,318
+83
+1% +$24.6K 0.06% 341
2014
Q1 		$1.87M Sell
6,235
-446
-7% -$137K 0.06% 325
2013
Q4 		$1.84M Sell
6,681
-6,102
-48% -$1.76M 0.06% 328
2013
Q3 		$4M Sell
12,783
-428
-3% -$113K 0.14% 148
2013
Q2 		$2.97M Buy
+13,211
New +$3.08M 0.1% 204

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Dai-ichi Life Holdings's REGN Position: Q4 2016 in Review

Dai-ichi Life Holdings sold out of Regeneron Pharmaceuticals (REGN) in Q4 2016, closing a stake of 10,434 shares — an estimated $4.2M sold.

Dai-ichi Life Holdings first reported a position in REGN in Q2 2013 and held it in 14 quarters. The position peaked at $7.25M in Q1 2015. 576 funds tracked by Wall St. Rank hold REGN as of Q4 2016.

  • Dai-ichi Life Holdings reported no remaining Regeneron Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Dai-ichi Life Holdings sold 10,434 Regeneron Pharmaceuticals shares in Q4 2016, an estimated $4.2M.
  • Dai-ichi Life Holdings first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 14 quarters.
  • Dai-ichi Life Holdings's Regeneron Pharmaceuticals position peaked at $7.25M in Q1 2015.
  • 576 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2016.

Based on Dai-ichi Life Holdings's 13F filing for Q4 2016, filed 14 Feb 2017.